Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients

被引:0
作者
Christelle Vauloup-Fellous
Sarah Maylin
Claire Périllaud-Dubois
Ségolène Brichler
Chakib Alloui
Emmanuel Gordien
Marie-Anne Rameix-Welti
Elyanne Gault
Frédérique Moreau
Slim Fourati
Dominique Challine
Jean-Michel Pawlotsky
Nadhira Houhou-Fidouh
Florence Damond
Vincent Mackiewicz
Charlotte Charpentier
Jean-François Méritet
Flore Rozenberg
Isabelle Podglajen
Stéphane Marot
Heloïse Petit
Sonia Burrel
Sepideh Akhavan
Marianne Leruez-Ville
Véronique Avettand-Fenoel
Jacques Fourgeaud
Tiffany Guilleminot
Elise Gardiennet
Stéphane Bonacorsi
Agnès Carol
Guislaine Carcelain
Juliette Villemonteix
Narjis Boukli
Joël Gozlan
Laurence Morand-Joubert
Jérome Legoff
Constance Delaugerre
Marie-Laure Chaix
Ana-Maria Roque-Afonso
Laurent Dortet
Thierry Naas
Jean-Baptiste Ronat
Samuel Lepape
Anne-Geneviève Marcelin
Diane Descamps
机构
[1] University Paris Saclay,AP–HP, Hôpital Paul
[2] INSERM U1193,Brousse, Virologie, Department of Virology
[3] Université de Paris,Département des Agents Infectieux, Service de Virologie, Hôpital Saint
[4] INSERM UMR 944,Louis
[5] Laboratoire de Microbiologie Clinique,Laboratoire de Microbiologie
[6] Centre national de référence des hépatites B,INSERM
[7] C et Delta,Department of Virology, Hôpital Henri Mondor, “Viruses, Hepatology, Cancer” Research Unit
[8] Hôpital Avicenne,Laboratoire de Virologie, AP
[9] Université Paris Nord,HP, Hôpital Bichat
[10] Unité INSERM U955,Claude Bernard
[11] AP-HP. Université Paris Saclay,Service de Virologie
[12] Hôpital Ambroise Paré,Service de Virologie
[13] Université Paris-Saclay,Institut Pierre Louis d’Epidémiologie et de Santé Publique, IPLESP, AP
[14] Université Paris-Est,HP, Hôpital Pitié
[15] INSERM U955,Salpêtrière, Laboratoire de virologie
[16] Université de Paris,APHP Laboratoire de Microbiologie clinique, Hôpital Necker
[17] INSERM UMR 1137 IAME,Service de Microbiologie, Hôpital Robert
[18] Hôpital Cochin - APHP Centre - Université de Paris,Debré
[19] Hôpital Européen Georges Pompidou-APHP Centre - Université de Paris,Laboratoire d’immunologie, Hôpital Robert
[20] Sorbonne Université,Debré
[21] INSERM,Département de Virologie (Hôpital Saint
[22] Université de Paris,Antoine, Tenon, Trousseau)
[23] Faculté de Médecine,Service de Bactériologie
[24] INSERM U1016,Hygiène, Hôpital Bicêtre, Inserm U 1184; LabEx LERMIT
[25] CNRS UMR 8104,undefined
[26] Institut Cochin,undefined
[27] Université de Paris,undefined
[28] Université de Paris,undefined
[29] AP-HP Sorbonne Université,undefined
[30] INSERM-Sorbonne Universités UPMC,undefined
[31] Université Paris 06,undefined
[32] UMR-S 1136,undefined
[33] Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP),undefined
[34] Université Paris-Saclay,undefined
来源
European Journal of Clinical Microbiology & Infectious Diseases | 2021年 / 40卷
关键词
Serology; SARS-CoV-2; COVID-19;
D O I
暂无
中图分类号
学科分类号
摘要
We report evaluation of 30 assays’ (17 rapid tests (RDTs) and 13 automated/manual ELISA/CLIA assay (IAs)) clinical performances with 2594 sera collected from symptomatic patients with positive SARS-CoV-2 rRT-PCR on a respiratory sample, and 1996 pre-epidemic serum samples expected to be negative. Only 4 RDT and 3 IAs fitted both specificity (> 98%) and sensitivity (> 90%) criteria according to French recommendations. Serology may offer valuable information during COVID-19 pandemic, but inconsistent performances observed among the 30 commercial assays evaluated, which underlines the importance of independent evaluation before clinical implementation.
引用
收藏
页码:2235 / 2241
页数:6
相关论文
共 85 条
[1]  
Huang C(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. Lancet 395 497-506
[2]  
Wang Y(2020)Clinical characteristics of coronavirus disease 2019 in China N Engl J Med 382 1708-20
[3]  
Li X(2020)Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy JAMA - J Am Med Assoc 323 1574-81
[4]  
Ren L(2020)Laboratory diagnosis of COVID-19: current issues and challenges J Clin Microbiol 58 e00512-20
[5]  
Zhao J(2020)Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes Emerg Microbes Infect 9 386-9
[6]  
Hu Y(2020)Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR Eurosurveillance 25 2000045-83
[7]  
Guan W(2020)Evaluation of SARS-CoV-2 serology assays reveals a range of test performance Nat Biotechnol 38 1174-94
[8]  
Ni Z(2020)Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies J Clin Virol 128 104413-400
[9]  
Hu Y(2020)Validation of a commercially available SARS-CoV-2 serological immunoassay Clin Microbiol Infect 26 1386-9
[10]  
Liang W(2020)An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment Nat Commun 11 3436-88